Clinical responses with T lymphocytes targeting malignancy-associated κ light chains
Carlos A. Ramos(Methodist Hospital), Gianpietro Dotti(Baylor College of Medicine)
Cited by 280
Related Papers
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
|Journal of Clinical Investigation|2017|368
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
|Blood|2015|312
Glycolysis determines dichotomous regulation of T cell subsets in hypoxia
|Journal of Clinical Investigation|2016|109
Activation of Wnt Signaling Arrests Effector Differentiation in Human Peripheral and Cord Blood-Derived T Lymphocytes
|The Journal of Immunology|2011|70